When I look at the current profit vs the MW utilised and extrapolate out as if the new DC's are full, I still get a very poor result. How come it isn't spitting out more EPS from the existing DC's, sufficient to avoid the large capital raising it recently did.
I also don't understand the "first mover advantage" premium that seems to be attributed to this company, as any later DC that is built uses newer lower power / higher performance / smaller size tech which makes it much more efficient. Existing DC's would surely become totally obsolete within 5-10 years if you can store the same amount of stuff in something a tenth of the size. If you say "but they can upgrade capacity as they go along", I just see that as further endless capex when the company isn't producing much EPS to start with.
Interested in holders thoughts or if anyone is an expert of some sort in DC's.
- Forums
- ASX - By Stock
- Ann: Half Year Results Presentation
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

When I look at the current profit vs the MW utilised and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online